Stock Ratings / Consumer Discretionary / NCI

PASW (34) TLF (43) FMFC (62) BIRD (37) ⌘ Pro Terminal →

Neo-Concept International Group Holdings Limited (Class A) (NCI) — RQD Stock Rating Cockpit

Q: What is NCI's 12-month price target and RQD AI Jury consensus?

NCI's 12-month base price target is $0.68 (range $0.53 to $116), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

$0.73 -1.68% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.73

Neo-Concept International Group Holdings Limited (Class A) (NCI) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • SELL / AVOID Cap $6.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.73 (-0.49%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 12.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.0% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-6.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NCI)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (42/100 Composite)

🔍 WHY NCI SCORES 42/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+12/20 pts (29% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+10/20 pts (24% of score)

SEC XBRL FY 2025 (10-K): 12.7% FCF Margin ($2.2M FCF) & 36.9% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$0.88-30.7% Next Q

Q2 (-2Q)

Grade D$0.61+29.5% Next Q

Q3 (-1Q)

Grade D$0.79-7.6% Next Q

Current

Grade D-$0.73-7% Hist 90D α

Trajectory: C- (50) → D- (42)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NCI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NCI currently carries a cautious 42/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($7.13) and Max Pain ($0.77) forces dealer call-delta covering toward $116.00.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NCI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NCI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 42%NO 58%Trade / Inspect Odds →

RSI-14 MOMENTUMOVERSOLD (<32)

17.730 Oversold · 70 Hot

ALTMAN-Z SHIELDDISTRESS RISK (<1.8)

1.49>3.0 Fortress Safe

PIOTROSKI F-SCORESOLID CORE (5–6)

6 / 99-Pt Accounting

52-WEEK LASER RANGE2% OF RANGE

L: $1$0.73H: $110

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 10 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 17 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D-RQD 15 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on NCI

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (50)

2.6% ROIC with 36.9% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (35)

Altman-Z 1.49 and Piotroski 6/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (42)

17/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like NCI

✓Established market leader in Consumer Discretionary with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Priced at 154x earnings—high expectations leave less room for a lukewarm quarter.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NCI)

✓Walkthrough of NCI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NCI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -91.30%🛡️ HOLDING TREND SUPPORT

2026-10-30O $0.70H $0.73L $0.65C $0.73VOL 83.5K

RES: $18.56SUP: $0.01SMA50: $7.13SMA200: $15.91

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NCI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NCI Butterfly Map → + Track NCI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. -41.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NCI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NCI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NCI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NCI)

Consumer Discretionary Rank #800 of 1011 ⚔️ PASW vs NCI Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (NCI vs. PASW, TLF, FMFC, BIRD)

Industry: Apparel (27 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Neo-Concept International Group Holdings Limited (Class A) (NCI) ranks #800 by composite RQD confidence (42/100, grade D-) and #952 by equity capitalization ($6.6M). Within this direct 5-issuer industry benchmark cohort, NCI leads on earnings valuation at 153.8x trailing P/E, while NCI leads on capital efficiency and profitability with 2.6% ROIC and 36.9% gross margin. FMFC currently holds the highest overall quantitative score in the immediate peer group at 62/100 (C) compared with NCI at 42/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NCI ACTIVE Neo-Concept International Group Holdings Limited (Class A)	D-	42/100	153.8x	36.9%	2.6%	-1.68%	$6.6M	Benchmark Subject
PASW Ping An Biomedical Co. Ltd. (Class A)	E	34/100	—	2.8%	—	-0.20%	$15.6M	/pasw-vs-nci →
TLF Tandy Leather Factory Inc.	D-	43/100	—	57.0%	-2.1%	+0.44%	$18.5M	/tlf-vs-nci →
FMFC Kandal M Venture Limited (Class A)	C	62/100	—	—	—	+3.83%	$1.9M	/fmfc-vs-nci →
BIRD Smartbird Inc. (Class A)	D-	37/100	—	41.0%	-35.0%	-0.93%	$25.0M	/bird-vs-nci →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001916331

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Neo-Concept International Group Holdings Limited (Class A) (NCI) reported GAAP revenue of $17.6M (-41.9% vs. FY2024 revenue of $30.3M , and -20.9% cumulative change since FY2023) , GAAP net income of $42.6K, operating cash flow of $2.7M, and free cash flow of $2.2M (+566.5% YoY). On the balance sheet, NCI closed FY2025 with $14.9M in total assets against $0 in total debt (Altman Z-Score: 1.49, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$17.6M	$42.6K	$2.7M	$2.2M	$14.9M	—
FY2024 (FY)	2024-12-31	$30.3M	$1.0M	$55.1K	-$478.4K	$17.5M	—
FY2023 (FY)	2023-12-31	$22.3M	$565.2K	-$6.3M	-$6.3M	—	—

3. NCI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NCI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Neo-Concept International Group Holdings Limited (Class A) (NASDAQ: NCI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $0.73 (-1.68% 1D, market cap $6.6M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 7/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, NCI ranks #800 in composite RQD confidence.

How does NCI compare to PASW and TLF in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Apparel), NCI carries a Roarable D- (42/100 RQD), trailing P/E of 153.8x, gross margin of 36.9%, and ROIC of 2.6%. By comparison, PASW (Ping An Biomedical Co. Ltd. (Class A)) holds a E grade (34/100 RQD, P/E N/A, ROIC —, cap $15.6M) and TLF (Tandy Leather Factory Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC -2.1%, cap $18.5M). Among the 5-stock peer group, NCI leads on earnings multiple (153.8x) while NCI leads on capital efficiency (2.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NCI?

Per NCI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001916331), Neo-Concept International Group Holdings Limited (Class A) generated $17.6M in revenue (-41.9% YoY), $42.6K in net income, and $2.2M in free cash flow against $14.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NCI trading relative to its 50-day, 200-day, and 52-week technical levels?

NCI last traded at $0.73 (-1.68% on volume of 71,647 shares), positioning the stock -89.76% below its 50-day simple moving average ($7.13) and -95.41% below its 200-day simple moving average ($15.91). Across its 52-week range of $0.57 to $110.48, NCI sits at the 0.1% percentile with a 14-day RSI of 17.7 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.82).

NCI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell NCI stock right now?

Neo-Concept International Group Holdings Limited (Class A) (NCI) currently earns a Roarable Rating of D- (Sell — SELL) with 42/100 RQD Confidence. Stretched risk/reward at 154x P/E (3% return on capital) under elevated 10-year interest-rate pressure.

What is NCI's 12-month price target and RQD AI Jury consensus?

NCI's 12-month base price target is $0.68 (range $0.53 to $116), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: NCI RQD Cockpit NCI 12M Forecast NCI Earnings & Move NCI Dividends & DRIP NCI Insiders & 13F NCI Whale Options NCI Profit Sankey NCI News & Why